Tempus AI, Inc. (NASDAQ:TEM) EVP Sells $5,071,893.52 in Stock

Tempus AI, Inc. (NASDAQ:TEM) EVP Erik Phelps sold 61,582 shares of Tempus AI stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $82.36, for a total transaction of $5,071,893.52. Following the sale, the executive vice president now directly owns 153,080 shares in the company, valued at $12,607,668.80. The trade was a 28.69 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Erik Phelps also recently made the following trade(s):

• On Wednesday, February 5th, Erik Phelps sold 5,934 shares of Tempus AI stock. The shares were sold at an average price of $67.57, for a total transaction of $400,960.38.

Tempus AI Stock Performance

Tempus AI stock traded down $8.99 during trading hours on Thursday, hitting $76.72. The stock had a trading volume of 20,409,815 shares, compared to its average volume of 14,385,644. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a 12-month low of $22.89 and a 12-month high of $91.45. The stock’s 50-day moving average price is $49.75 and its 200-day moving average price is $51.44.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in TEM. Operose Advisors LLC purchased a new position in shares of Tempus AI during the fourth quarter valued at approximately $25,000. First Horizon Advisors Inc. purchased a new position in shares of Tempus AI during the third quarter valued at approximately $30,000. Farther Finance Advisors LLC purchased a new position in shares of Tempus AI during the fourth quarter valued at approximately $34,000. Prestige Wealth Management Group LLC raised its holdings in shares of Tempus AI by 910.4% during the fourth quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock valued at $36,000 after purchasing an additional 965 shares during the last quarter. Finally, NewEdge Advisors LLC purchased a new position in shares of Tempus AI during the fourth quarter valued at approximately $49,000. 24.22% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently commented on TEM. Loop Capital dropped their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Piper Sandler reissued a “neutral” rating and set a $70.00 price objective (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Guggenheim began coverage on shares of Tempus AI in a research note on Monday, December 9th. They set a “buy” rating and a $74.00 price objective on the stock. Bank of America boosted their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research note on Friday, December 13th. Finally, William Blair lowered shares of Tempus AI from an “outperform” rating to a “market perform” rating in a research note on Wednesday, February 12th. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, Tempus AI currently has a consensus rating of “Moderate Buy” and a consensus target price of $58.55.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.